TG Therapeutics Inc

Common Name

TG Therapeutics

Country

United States

Sector

Healthcare

Industry

Biotechnology

Employees

370

Ticker

TGTX

Exchange

NASDAQ CAPITAL MARKET

Website

www.tgtherapeutics.com

Description

TG Therapeutics, Inc. is a biopharmaceutical company focused on developing and commercializing therapies for **B‑cell–mediated diseases**, with a primary emphasis on multiple sclerosis and hematologic... Show more

Financial Statements of TG Therapeutics

Below are the financial statements of TG Therapeutics, including the income statement and balance sheet for the company's latest fiscal year. All figures are accurate, verifiable, and fully traceable to the original annual filing where disclosed.

Income Statement (as reported) Balance Sheet (as reported)

All figures in millions of USD	2024	2023
Current assets	—	—
Cash and cash equivalents	179.89^a	92.93^a
Short-term investment securities	131.11^a	124.58^a
Accounts receivable, net	129.19^a	51.09^a
Inventories	110.46^a	39.82^a
Other current assets	15.72^a	9.52^a
Total current assets	566.36^a	317.94^a
Assets	—	—
Restricted cash	1.3^a	1.29^a
Long-term investment securities	0.81^a	0^a
Right of use assets	7.15^a	8.05^a
Other noncurrent assets	2.07^a	2.31^a
Total assets	577.69^a	329.59^a
Current liabilities	—	—
Accounts payable and accrued expenses	58.3^a	38.47^a
Other current liabilities	4.63^a	1.48^a
Lease liability - current portion	1.16^a	1.45^a
Deferred revenue - current portion	11.41^a	0.15^a
Accrued compensation	15.19^a	12.17^a
Total current liabilities	90.68^a	53.72^a
Liabilities and stockholders’ equity	—	—
Deferred revenue, non-current portion	12.09^a	6.02^a
Loan payable	244.43^a	100.12^a
Lease liability - non-current	8.13^a	9.23^a
Total liabilities	355.33^a	169.09^a
Stockholders’ equity	—	—
Common stock	0.16^a	0.15^a
Additional paid-in capital	1,760.4^a	1,713.16^a
Treasury stock, at cost	-8.99^a	-0.23^a
Accumulated deficit	-1,529.19^a	-1,552.58^a
Total stockholders’ equity	222.36^a	160.5^a
Total liabilities and stockholders’ equity	577.69^a	329.59^a

Verified Sources Behind TG Therapeutics’s Financial Fundamentals Data

Every figure on this dashboard has a transparent audit trail. With Tracenable, each data point is traceable back to its original source, viewable directly inside our platform. Explore TG Therapeutics’s data sources below and access millions more through our Disclosure Search.

a. TG Therapeutics's 10-K 2024

Trace every data point back to TG Therapeutics’s disclosures

Sign up for Tracenable and access millions of corporate disclosures, including annual reports and sustainability filings from global companies, completely free of charge.

Real-Time & Standardized Financials

Access Standardized Financial Statements within Minutes of Disclosure

At Tracenable, we're exploring the launch of real-time standardized financial datafeeds and APIs covering global equities. Unlike limited and inconsistent XBRL parsing, our approach aims to deliver clean, comparable, and fully traceable data seconds after publication.

Could this solution support your investment or analytical workflows?

Explore Peer Companies

Welcome Back to Tracenable

Sign in to your account

TG Therapeutics Inc

Financial Statements of TG Therapeutics

Verified Sources Behind TG Therapeutics’s Financial Fundamentals Data

Access Standardized Financial Statements within Minutes of Disclosure

Explore Peer Companies

SpringWorks Therapeutics Inc

Iovance Biotherapeutics Inc

Blueprint Medicines Corp

Insmed Inc

Ultragenyx Pharmaceutical Inc

BridgeBio Pharma Inc